PCV24

24-valent pneumococcal conjugate vaccine · Shanghai Reinovax Biologics Co., LTD

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for PCV24, covering 2024-11-07 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of PCV24 in Adults Aged ≥18 Years [Phase 1, Phase 2]